Drugmakers roll out seasonal flu vaccine

Manufacturers have begun shipping the planned 155 million doses of 2010/2011 seasonal flu shots and sprays for the U.S. Sanofi Pasteur says it has shipped the first of its 70 million doses. Novartis plans to supply about 40 million doses; GSK, 30 million. MedImmune has begun shipping 15 million sprays. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.